Resident Basic Exam Scores Linked to ABD Certification Results, Cureus Finds
Updated

A study published in Cureus reports a correlation between dermatology residents' scores on the basic in-training examination and their eventual performance on the American Board of Dermatology certification exam under the board's newer testing pathway.
The paper — "Dermatology Resident Basic Exam Scores Are Correlated With American Board of Dermatology Certification Examination Outcomes in the New Certification Model" — takes up a question residency program directors have asked since the ABD restructured its certification process: does the basic exam still predict who passes?
What did the study examine?
The analysis evaluated how resident performance on the basic exam — generally taken during the second or third postgraduate year — relates to outcomes on the ABD certification examination administered under the updated testing model. The "new certification model" referenced in the title reflects the ABD's shift away from a single high-stakes examination toward a more modular assessment structure that has rolled out over the past several years.
Why does the correlation matter?
For program directors, the basic exam has long served as an early signal. A resident whose basic scores lag is a resident who may need additional board-prep support before sitting for the certifying exam. That signal shapes how programs allocate remediation time, mentor pairings, and study resources across the three-year residency.
Under the previous exam structure, the relationship between basic-exam performance and certification success was well documented. The open question — and the one this Cureus paper appears to address — is whether that relationship holds under the ABD's restructured pathway.
What does this change for program directors?
Practically, the finding suggests the basic exam remains a useful checkpoint rather than a vestigial exercise. Programs that already use basic-exam performance as a triage tool for board preparation can keep doing so with reasonable confidence that the scores track downstream certification success.
It also gives program directors a defensible evidence base when they argue internally — or with their designated institutional officials — that protected study time for the basic exam is worth preserving. In an environment where every protected week is contested, peer-reviewed data showing predictive validity is useful currency.
What the title does not tell us
The Cureus title confirms a correlation but does not, on its own, disclose the effect size, sample size, statistical method, or pass-rate breakdown. Readers planning to cite the paper or revise program-level board-prep policy should pull the full text for the numerical details — including whether the correlation holds for first-time test takers, for residents at specific PGY levels, or across programs of different sizes.
The paper's placement in Cureus, an open-access journal, also makes it more readily available to program directors and residents than subscription-only alternatives.
How this fits the broader testing picture
The ABD's certification restructure has been one of the more closely watched changes in graduate medical education over the last several years. It has drawn support for its longitudinal philosophy and criticism for the operational complexity it has introduced for residents and program directors alike.
Data points that clarify how the older in-training assessments perform against the newer examination structure are therefore likely to draw attention from the residency education community. The Cureus paper joins a small but growing body of work tracking how the basic exam, the applied exam, and other assessment tools line up with certification outcomes under the updated pathway.
For program directors who build curriculum around early signals, the takeaway is straightforward: the basic exam still appears to earn its place on the calendar.
Source: Google News: Dermatology
Olivia Hart
Show full bio
News editor covering technology and product news in Clinical dermatology, inflammatory skin disease and biologics at Derm Field.